John E. Crawford
Director/Miembro de la Junta en The University of Chicago Cancer Research Foundation .
Origen de la red de primer grado John E. Crawford.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
The University of Chicago Cancer Research Foundation
22
| Foundation/Endowment | 22 | |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection. The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.
20
| Extinct | Pharmaceuticals: Major | 20 |
Corvas International, Inc.
7
| Extinct | Pharmaceuticals: Major | 7 |
Lipid Sciences, Inc.
Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Cabrellis Pharmaceuticals Corp.
Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
International Genetic Engineering, Inc.
International Genetic Engineering, Inc. Engineering & ConstructionIndustrial Services International Genetic Engineering, Inc. provides engineering services. The private company is based in Santa Monica, CA. The company was founded by Gary L. Wilcox.
1
| Private Company | Engineering & Construction | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a John E. Crawford a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
LJL Biosystems, Inc.
LJL Biosystems, Inc. Medical DistributorsDistribution Services LJL BioSystems, Inc. develops, designs, produces and sells infrastructure tools for drug discovery. Its products are used in the discovery process of screening and genotyping. It serves pharmaceutical, biotechnology and genomics companies as well as research institutions. The company is located in Sunnyvale, CA. | Medical Distributors | Director/Board Member Director/Board Member | |
INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Wildcat Discovery Technologies, Inc.
Wildcat Discovery Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Wildcat Discovery Technologies, Inc. provides commercial research and development services. The firm engages in development projects for materials for other applications, including gas storage, carbon capture, thermoelectric, and structural materials. Its products include electrolyte additives such as EM1, CM1, CM2, and EM2. The company was founded by Peter G. Schultz and Robert K. Downs in 2006 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Afraxis, Inc.
Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Founder | |
RECEPTOS INC | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Rice University | College/University | Undergraduate Degree Undergraduate Degree | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Chairman | |
Wake Forest University | College/University | Doctorate Degree Undergraduate Degree | |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Medical/Nursing Services | President Corporate Officer/Principal | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Corporate Officer/Principal | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Indiana University | College/University | Undergraduate Degree Doctorate Degree | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree Director/Board Member | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Graduate Degree Graduate Degree | |
University of California, Berkeley | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
University of Iowa | College/University | Undergraduate Degree Undergraduate Degree | |
AMBRX INC | Pharmaceuticals: Major | Founder Chairman | |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Founder Corporate Officer/Principal | |
Panorama Capital LLC
Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Investment Managers | Founder Chief Investment Officer Private Equity Analyst | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO |
Estadísticas
Internacional
Estados Unidos | 47 |
Australia | 3 |
Nueva Zelanda | 2 |
Sectorial
Health Technology | 28 |
Consumer Services | 13 |
Finance | 5 |
Commercial Services | 4 |
Distribution Services | 2 |
Operativa
Director/Board Member | 328 |
Corporate Officer/Principal | 141 |
Independent Dir/Board Member | 77 |
Founder | 63 |
Chairman | 55 |
Las relaciones más conectadas
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
Daniel Janney | 47 |
Eckard Weber | 46 |
Deepa Pakianathan | 32 |
Julie Cherrington | 32 |
David Kabakoff | 30 |
John Diekman | 29 |
Ruth Ann Gillis | 28 |
Peter G. Schultz | 21 |
Robin Josephs | 18 |
Laura Shawver | 18 |
Howard C. Dittrich | 17 |
Vernon Bernardino | 16 |
D. W. E. Wicker | 16 |
Chris LeMasters | 15 |
- Bolsa de valores
- Insiders
- John E. Crawford
- Conexiones Empresas